News
Medication is not a quick fix for obesity, Dr. Samuel L. Wilcox said during a "Lunch & Learn" session at the Iola Public ...
GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and ...
5h
The Print on MSNIn battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on otherIndia's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.
An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...
Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...
A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
Signs of advanced chronic pancreatitis include weight loss, a loss of appetite, jaundice, other symptoms associated with ...
A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...
The once-monthly drug is still under study but could provide added convenience and another option for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results